Search research articles
Contact Us
Filters
Showing results (41-50 of 137) with videos related to
Page
of 14
Sort By:
Journal for Immunotherapy of Cancer
|
February 14, 2018
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients
Michael T Tetzlaff, Kelly C Nelson, Adi Diab, et al.
Journal of Cutaneous Pathology
|
November 19, 2016
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Jonathan L Curry, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
Plos One
|
May 11, 2010
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation
Adam D Cohen, David A Schaer, Cailian Liu, et al.
JMIR Cancer
|
October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 15, 2020
TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis
Nisha S Ramani, Phyu P Aung, Jun Gu, et al.
Journal for Immunotherapy of Cancer
|
November 23, 2019
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
Houssein Safa, Daniel H Johnson, Van Anh Trinh, et al.
Cancer Immunology Research
|
September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Frontiers in Immunology
|
June 20, 2022
B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade
Shubhra Singh, Jason Roszik, Neeraj Saini, et al.
Neuro-Oncology Practice
|
July 15, 2024
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma
Chantal Saberian, Denái R Milton, Julie Simon, et al.
Journal of Cutaneous Pathology
|
June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 137) with videos related to
Sort By:
Page
of 14
Journal for Immunotherapy of Cancer
|
February 14, 2018
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients
Michael T Tetzlaff, Kelly C Nelson, Adi Diab, et al.
Journal of Cutaneous Pathology
|
November 19, 2016
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Jonathan L Curry, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
Plos One
|
May 11, 2010
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation
Adam D Cohen, David A Schaer, Cailian Liu, et al.
JMIR Cancer
|
October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 15, 2020
TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis
Nisha S Ramani, Phyu P Aung, Jun Gu, et al.
Journal for Immunotherapy of Cancer
|
November 23, 2019
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
Houssein Safa, Daniel H Johnson, Van Anh Trinh, et al.
Cancer Immunology Research
|
September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Frontiers in Immunology
|
June 20, 2022
B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade
Shubhra Singh, Jason Roszik, Neeraj Saini, et al.
Neuro-Oncology Practice
|
July 15, 2024
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma
Chantal Saberian, Denái R Milton, Julie Simon, et al.
Journal of Cutaneous Pathology
|
June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Page
of 14